A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Clinical trial NCT03787498 · COMPLETED

Trial details

NCT number: NCT03787498
Sponsor: Opna Bio LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Acute Myeloid Leukemia (AML)Refractory Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)

Start date: 2019-03-19
Primary completion: 2021-06-30
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.